Year-over-year, this metric declined by 100.0%, from $12.75B to $0.00. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -12.4% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.08B | $13.46B | $20.06B | $9.51B | $5.23B | $6.35B | $6.86B | $9.37B | $898.00M | $3.57B | $5.94B | $15.01B | $6.30B | $8.82B | $0.00 | $12.75B | $10.17B | $3.33B | $0.00 | $0.00 |
| QoQ Change | — | +90.1% | +49.1% | -52.6% | -45.0% | +21.4% | +8.0% | +36.5% | -90.4% | +297.4% | +66.5% | +152.6% | -58.0% | +40.0% | -100.0% | — | -20.3% | -67.3% | -100.0% | — |
| YoY Change | — | — | — | — | -26.1% | -52.8% | -65.8% | -1.5% | -82.8% | -43.8% | -13.4% | +60.3% | +601.4% | +147.1% | -100.0% | -15.0% | +61.4% | -62.3% | — | -100.0% |